Title | Camrelizumab plus apatinib in extensive-stage small-cell lung cancer (PASSION): A multicenter, two-stage, phase 2 trial |
Authors | Wang, Jie Fan, Yun Zhao, Jun Wang, Qiming Huang, Dingzhi Li, Xingya Chen, Jianhua Fang, Yong Wang, Zhijie Zhou, Caicun Hu, Yanping Yang, Haihua Hu, Yi Zhou, Jianying Lin, Xiaoyan Wang, Lifeng Xu, Yanjun Li, Hanying |
Affiliation | Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China Zhejiang Canc Hosp, Hangzhou, Peoples R China Beijing Canc Hosp, Beijing, Peoples R China Henan Canc Hosp, Zhengzhou, Peoples R China Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China Hunan Canc Hosp, Changsha, Peoples R China Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China Tongji Univ, Shanghai Pulm Hosp, Shanghai, Peoples R China Hubei Canc Hosp, Wuhan, Peoples R China Taizhou Hosp Zhejiang Prov, Taizhou, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Peoples R China Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China Nanjing Univ, Med Sch, Drum Tower Hosp, Nanjing, Peoples R China Jiangsu Hengrui Med Co Ltd, Shanghai, Peoples R China |
Issue Date | Aug-2020 |
Publisher | CANCER RESEARCH |
URI | http://hdl.handle.net/20.500.11897/621742 |
ISSN | 0008-5472 |
DOI | 10.1158/1538-7445.AM2020-CT083 |
Indexed | SCI(E) CPCI-S(ISTP) |
Appears in Collections: | 待认领 |